Previous experimental studies reported that RHO has an anti-inflammatory impact on myocardial ischemia by inhibiting the PI3K/Akt/mTOR pathway in vivo and the TLR4/NF-κB signaling pathway [51]. This evidence concerns the gene TLR4 and myocardial ischemia.